Skip to main content
Top
Published in: International Ophthalmology 6/2019

01-06-2019 | Original Paper

Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson’s disease

Authors: Samir Hasanov, Elif Demirkilinc Biler, Ahmet Acarer, Cezmi Akkın, Zafer Colakoglu, Onder Uretmen

Published in: International Ophthalmology | Issue 6/2019

Login to get access

Abstract

Purpose

To evaluate and follow-up of functional and morphological changes of the optic nerve and ocular structures prospectively in patients with early-stage Parkinson’s disease.

Materials and methods

Nineteen patients with a diagnosis of early-stage Parkinson’s disease and 19 age-matched healthy controls were included in the study. All participants were examined minimum three times at the intervals of at least 6 month following initial examination. Pattern visually evoked potentials (VEP), contrast sensitivity assessments at photopic conditions, color vision tests with Ishihara cards and full-field visual field tests were performed in addition to measurement of retinal nerve fiber layer (RNFL) thickness of four quadrants (top, bottom, nasal, temporal), central and mean macular thickness and macular volumes.

Results

Best corrected visual acuity was observed significantly lower in study group within all three examinations. Contrast sensitivity values of the patient group were significantly lower in all spatial frequencies. P100 wave latency of VEP was significantly longer, and amplitude was lower in patient group; however, significant deterioration was not observed during the follow-up. Although average peripapillary RNFL thickness was not significant between groups, RNFL thickness in the upper quadrant was thinner in the patient group. While there was no difference in terms of mean macular thickness and total macular volume values between the groups initially, a significant decrease occurred in the patient group during the follow-up. During the initial and follow-up process, a significant deterioration in visual field was observed in the patient group.

Conclusion

Structural and functional disorders shown as electro-physiologically and morphologically exist in different parts of visual pathways in early-stage Parkinson’s disease.
Literature
1.
go back to reference Archibald NK, Clarke MP, Mosimann UP et al (2009) The retina in Parkinson’s disease. Brain 132:1128–1145CrossRefPubMed Archibald NK, Clarke MP, Mosimann UP et al (2009) The retina in Parkinson’s disease. Brain 132:1128–1145CrossRefPubMed
2.
go back to reference Repka MX, Claro MC, Loupe DN et al (1996) Ocular motility in Parkinson’s disease. J Pediatr Ophthalmol Strabismus 33:144–147PubMed Repka MX, Claro MC, Loupe DN et al (1996) Ocular motility in Parkinson’s disease. J Pediatr Ophthalmol Strabismus 33:144–147PubMed
3.
go back to reference Barnes J, David AS (2001) Visual hallucinations in Parkinson’s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70:727–733CrossRefPubMedPubMedCentral Barnes J, David AS (2001) Visual hallucinations in Parkinson’s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70:727–733CrossRefPubMedPubMedCentral
4.
go back to reference Biousse V, Skibell BC, Watts RL et al (2004) Ophthalmologic features of Parkinson’s disease [see comment]. Neurology 62:177–180CrossRefPubMed Biousse V, Skibell BC, Watts RL et al (2004) Ophthalmologic features of Parkinson’s disease [see comment]. Neurology 62:177–180CrossRefPubMed
5.
go back to reference Sari ES, Koc R, Yazici A, Sahin G, Cakmak H, Kocaturk T, Ermis SS (2015) Tear osmolarity, break-up time and Schirmer’s scores in Parkinson’s disease. Turk J Ophthalmol 45:142–145CrossRef Sari ES, Koc R, Yazici A, Sahin G, Cakmak H, Kocaturk T, Ermis SS (2015) Tear osmolarity, break-up time and Schirmer’s scores in Parkinson’s disease. Turk J Ophthalmol 45:142–145CrossRef
6.
go back to reference Goetz CG, Fan W, Leurgans S et al (2006) The malignant course of ‘benign hallucinations’ in Parkinson disease. Arch Neurol 63:713–716CrossRefPubMed Goetz CG, Fan W, Leurgans S et al (2006) The malignant course of ‘benign hallucinations’ in Parkinson disease. Arch Neurol 63:713–716CrossRefPubMed
8.
go back to reference Moreno MC, Giagante B, Saidon P et al (2005) Visual defects associated üith vigabatrin: a study of epileptic Argentine patients. Can J Neurol Sci 32:459–464CrossRefPubMed Moreno MC, Giagante B, Saidon P et al (2005) Visual defects associated üith vigabatrin: a study of epileptic Argentine patients. Can J Neurol Sci 32:459–464CrossRefPubMed
9.
10.
go back to reference De Rijk MC, Breteler MM, Graveland GA et al (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam study. Neurology 45:2143–2146CrossRefPubMed De Rijk MC, Breteler MM, Graveland GA et al (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam study. Neurology 45:2143–2146CrossRefPubMed
11.
go back to reference Satue M, Garcia-Martin E, Fuertes I et al (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond) 27:507–514CrossRef Satue M, Garcia-Martin E, Fuertes I et al (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond) 27:507–514CrossRef
12.
go back to reference Archibald NK, Clarke MP, Mosimann UP et al (2011) Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 26:2387–2395CrossRefPubMed Archibald NK, Clarke MP, Mosimann UP et al (2011) Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 26:2387–2395CrossRefPubMed
14.
go back to reference Stemplewitz B, Keserü M, Bittersohl D et al (2015) Scanning laser polarimetry and sprctral domain optical coherence tomography for the detection of retinal changes in Parkinson’s disease. Acta Ophthalmol 93:672–677CrossRef Stemplewitz B, Keserü M, Bittersohl D et al (2015) Scanning laser polarimetry and sprctral domain optical coherence tomography for the detection of retinal changes in Parkinson’s disease. Acta Ophthalmol 93:672–677CrossRef
15.
go back to reference Sari ES, Koc R, Yazici A et al (2015) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association wiht disease severity and duration. J Neuroophthalmol 35:117–121PubMed Sari ES, Koc R, Yazici A et al (2015) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association wiht disease severity and duration. J Neuroophthalmol 35:117–121PubMed
16.
go back to reference Kaur M, Saxena R, Singh D et al (2015) Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol 35:254–258CrossRefPubMed Kaur M, Saxena R, Singh D et al (2015) Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol 35:254–258CrossRefPubMed
17.
go back to reference Sacca SC, Bolognesi C, Battistella A et al (2009) Gene-environment interactions in ocular diseases. Mutat Res 66:98–117CrossRef Sacca SC, Bolognesi C, Battistella A et al (2009) Gene-environment interactions in ocular diseases. Mutat Res 66:98–117CrossRef
18.
go back to reference Tsironi EE, Dastiridou A, Katsanos A et al (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12:54CrossRefPubMedPubMedCentral Tsironi EE, Dastiridou A, Katsanos A et al (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12:54CrossRefPubMedPubMedCentral
19.
go back to reference Bayer AU, Keller ON, Ferrari F et al (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer’s disease and Parkinson’s disease. Am J Ophthalmol 133:135–137CrossRefPubMed Bayer AU, Keller ON, Ferrari F et al (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer’s disease and Parkinson’s disease. Am J Ophthalmol 133:135–137CrossRefPubMed
20.
go back to reference Yenice O, Onal S, Midi I et al (2008) Visual field analysis in patients with Parkinson’s disease. Parkinsonism Relat Disord 14:193–198CrossRefPubMed Yenice O, Onal S, Midi I et al (2008) Visual field analysis in patients with Parkinson’s disease. Parkinsonism Relat Disord 14:193–198CrossRefPubMed
21.
22.
go back to reference Langheinrich T, Tebartz van Elst L, Lagreze WA et al (2000) Visual contrast response functions in Parkinson’s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 111:66–74CrossRefPubMed Langheinrich T, Tebartz van Elst L, Lagreze WA et al (2000) Visual contrast response functions in Parkinson’s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 111:66–74CrossRefPubMed
23.
go back to reference Pieri V, Diederich NJ, Raman R et al (2000) Decreased colour discrimination and contrast sensitivity in Parkinson’s disease. J Neurol Sci 172:7–11CrossRefPubMed Pieri V, Diederich NJ, Raman R et al (2000) Decreased colour discrimination and contrast sensitivity in Parkinson’s disease. J Neurol Sci 172:7–11CrossRefPubMed
24.
go back to reference Miri S, Glazman S, Mylin L et al (2016) A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):134–137CrossRef Miri S, Glazman S, Mylin L et al (2016) A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):134–137CrossRef
25.
go back to reference Kupersmith MJ, Shakin E, Siegel IM et al (1982) Visual system abnormalities in patients with Parkinson’s disease. Arch Neurol 39:284–286CrossRefPubMed Kupersmith MJ, Shakin E, Siegel IM et al (1982) Visual system abnormalities in patients with Parkinson’s disease. Arch Neurol 39:284–286CrossRefPubMed
26.
go back to reference Hutton JT, Morris JL, Elias JW et al (1991) Spatial contrast sensitivity is reduced bilaterally in Parkinson’s disease. Neurology 41:1200–1202CrossRefPubMed Hutton JT, Morris JL, Elias JW et al (1991) Spatial contrast sensitivity is reduced bilaterally in Parkinson’s disease. Neurology 41:1200–1202CrossRefPubMed
27.
go back to reference Buttner T, Muller T, Kuhn W (2000) Effects of apomorphine on visual functions in Parkinson’s disease. J Neural Transm 107:87–94CrossRefPubMed Buttner T, Muller T, Kuhn W (2000) Effects of apomorphine on visual functions in Parkinson’s disease. J Neural Transm 107:87–94CrossRefPubMed
28.
go back to reference Birch J, Kolle RU, Kunkel M et al (1998) Acquired colour deficiency in patients with Parkinson’s disease. Vis Res 38:3421–3426CrossRefPubMed Birch J, Kolle RU, Kunkel M et al (1998) Acquired colour deficiency in patients with Parkinson’s disease. Vis Res 38:3421–3426CrossRefPubMed
29.
go back to reference Oh YS, Kim JS, Chunq SW et al (2011) Color vision in Parkinson`s disease and essential tremor. Eur J Neurol 18:577–583CrossRefPubMed Oh YS, Kim JS, Chunq SW et al (2011) Color vision in Parkinson`s disease and essential tremor. Eur J Neurol 18:577–583CrossRefPubMed
30.
31.
go back to reference Dowling JE (1990) Functional and pharmacological organization of the retina: dopamine, interplexiform cells, and neuromodulation. In: Cohen B, Bodis-Wollner I (eds) Vision and the brain: the organization of the central visual system. Raven Press, New York, pp 1–18 Dowling JE (1990) Functional and pharmacological organization of the retina: dopamine, interplexiform cells, and neuromodulation. In: Cohen B, Bodis-Wollner I (eds) Vision and the brain: the organization of the central visual system. Raven Press, New York, pp 1–18
32.
go back to reference Castelo-Branco M, Faria P, Forjaz V et al (2004) Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Investig Ophthalmol Vis Sci 45:499–505CrossRef Castelo-Branco M, Faria P, Forjaz V et al (2004) Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Investig Ophthalmol Vis Sci 45:499–505CrossRef
33.
go back to reference Campos SH, Forjaz V, Kozak LR et al (2005) Quantitative phenotyping of chromati dysfunction in best macular dystrophy. Arch Ophthalmol 123:944–949CrossRefPubMed Campos SH, Forjaz V, Kozak LR et al (2005) Quantitative phenotyping of chromati dysfunction in best macular dystrophy. Arch Ophthalmol 123:944–949CrossRefPubMed
34.
go back to reference Buttner TH, Kuhn W, Müller TH et al (1996) Chromatic and achromatic visual evoked potentials in Parkinson’s disease. Electroenceph Clin Neurophysiol 100:443–447CrossRefPubMed Buttner TH, Kuhn W, Müller TH et al (1996) Chromatic and achromatic visual evoked potentials in Parkinson’s disease. Electroenceph Clin Neurophysiol 100:443–447CrossRefPubMed
35.
go back to reference Dinner DS, Lüders H, Hanson M et al (1985) Pattern evoked potentials (PEPS) in Parkinson’s disease. Neurology 35:610–613CrossRefPubMed Dinner DS, Lüders H, Hanson M et al (1985) Pattern evoked potentials (PEPS) in Parkinson’s disease. Neurology 35:610–613CrossRefPubMed
36.
go back to reference Barbato L, Rinalduzzi S, Laurenti M et al (1994) Color VEPs in Parkinson’s disease. Electroenceph Clin Neurophysiol 92:169–172CrossRefPubMed Barbato L, Rinalduzzi S, Laurenti M et al (1994) Color VEPs in Parkinson’s disease. Electroenceph Clin Neurophysiol 92:169–172CrossRefPubMed
37.
go back to reference Altintas O, Iseri P, Ozkan B et al (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 1116:137–146CrossRef Altintas O, Iseri P, Ozkan B et al (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 1116:137–146CrossRef
38.
go back to reference Moschos MM, Tagaris G, Markopoulos I et al (2010) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24–29CrossRef Moschos MM, Tagaris G, Markopoulos I et al (2010) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24–29CrossRef
39.
go back to reference Garcia-Martin E, Satue M, Fuertes I et al (2012) Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson’s disease. Ophthalmology 119:2161–2167CrossRefPubMed Garcia-Martin E, Satue M, Fuertes I et al (2012) Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson’s disease. Ophthalmology 119:2161–2167CrossRefPubMed
40.
go back to reference Kirbas S, Turkyilmaz K, Tufekci A et al (2013) Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 33:62–65CrossRefPubMed Kirbas S, Turkyilmaz K, Tufekci A et al (2013) Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 33:62–65CrossRefPubMed
41.
go back to reference Garcia-Martin E, Rodrigues-Mena D, Satue M et al (2014) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Investig Ophthalmol Vis Sci 55:696–705CrossRef Garcia-Martin E, Rodrigues-Mena D, Satue M et al (2014) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Investig Ophthalmol Vis Sci 55:696–705CrossRef
42.
43.
go back to reference Aaker GD, Myung JS, Ehrlich JR et al (2010) Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427–1432PubMedPubMedCentral Aaker GD, Myung JS, Ehrlich JR et al (2010) Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427–1432PubMedPubMedCentral
44.
go back to reference Archibald NK, Clarke MP, Mosimann UP et al (2011) Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord 17:431–436CrossRefPubMed Archibald NK, Clarke MP, Mosimann UP et al (2011) Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord 17:431–436CrossRefPubMed
47.
go back to reference Hajee M, March W, Lazzaro D et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737–741CrossRefPubMed Hajee M, March W, Lazzaro D et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737–741CrossRefPubMed
48.
go back to reference Adam C, Shrier E, Bodis-Wollner I et al (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33:137–142CrossRefPubMed Adam C, Shrier E, Bodis-Wollner I et al (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33:137–142CrossRefPubMed
Metadata
Title
Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson’s disease
Authors
Samir Hasanov
Elif Demirkilinc Biler
Ahmet Acarer
Cezmi Akkın
Zafer Colakoglu
Onder Uretmen
Publication date
01-06-2019
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 6/2019
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-018-0934-y

Other articles of this Issue 6/2019

International Ophthalmology 6/2019 Go to the issue